Gene therapy may treat obesity
By Times of India,
Times of India
| 03. 10. 2009
Alarmed by the rise in obesity, researchers are examining the possibility of injecting a gene directly into one of the critical feeding and weight control centres of the brain.
"Obesity significantly increases the risk for diabetes, cardiovascular disease, stroke and some cancers," said Matthew During, the study's co-author and professor at Ohio State University Medical Centre.
"Our findings represent a promising new treatment for obesity that could ultimately provide a much safer and more effective approach than some conventional therapies," he said.
Scientists have discovered that a particular gene, BDNF, when active in the hypothalamus, can result in improved insulin sensitivity, reduced fat mass and weight loss.
Lei Cao, a co-author and assistant professor of molecular virology, immunology and medical genetics, said the study involved injecting the BDNF gene in normal mice, diabetic mice and mice fed with a high fat diet, to determine how the gene transfer would affect their weight.
"The gene was active in the overweight mice but as they lost weight, the gene expression was essentially 'dialed down,' using a novel RNA interference approach, thus stopping...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...